新型
昨日、インフルエンザのAが来ましたが、（患者から）もう保健所からは新型かどうかの検査はしないと言われたそうです。また、応援に行っている基幹病院の（新型インフル用の）隔離のプレハブ室も撤去されていました。とうとう蔓延状態となりました。
昨日、インフルエンザのAが来ましたが、（患者から）もう保健所からは新型かどうかの検査はしないと言われたそうです。また、応援に行っている基幹病院の（新型インフル用の）隔離のプレハブ室も撤去されていました。とうとう蔓延状態となりました。あの水際作戦に注ぎ込んだ資源（マンパワーとマニー）を、現在の蔓延対策として使ったら良かったと考えるのは私だけなんでしょうか。
一部（多く？）のマスコミは、かかったと思ったら早めに医療機関へ、そしてタミフルっていう感じですが、これが対策なのか？と思います。CDCのサイトには以下のように。でも日本の公的機関のサイトにはわかりやすいものはないのですね。
The symptoms of novel H1N1 flu virus in people are similar to the symptoms of seasonal flu and include fever, cough, sore throat, runny or stuffy nose, body aches, headache, chills and fatigue. A significant number of people who have been infected with novel H1N1 flu virus also have reported diarrhea and vomiting. The high risk groups for novel H1N1 flu are not known at this time, but it’s possible that they may be the same as for seasonal influenza. People at higher risk of serious complications from seasonal flu include people age 65 years and older, children younger than 5 years old, pregnant women, people of any age with chronic medical conditions (such as asthma, diabetes, or heart disease), and people who are immunosuppressed (e.g., taking immunosuppressive medications, infected with HIV).
There are two influenza antiviral medications that are recommended for use against novel H1N1 flu. The drugs that are used for treating novel H1N1 flu are called oseltamivir (trade name Tamiflu ®) and zanamivir (Relenza ®). As the novel H1N1 flu spreads, these antiviral drugs may become in short supply. Therefore, the drugs may be given first to those people who have been hospitalized or are at high risk of severe illness from flu. The drugs work best if given within 2 days of becoming ill, but may be given later if illness is severe or for those at a high risk for complications.
一部（多く？）のマスコミは、かかったと思ったら早めに医療機関へ、そしてタミフルっていう感じですが、これが対策なのか？と思います。CDCのサイトには以下のように。でも日本の公的機関のサイトにはわかりやすいものはないのですね。
The symptoms of novel H1N1 flu virus in people are similar to the symptoms of seasonal flu and include fever, cough, sore throat, runny or stuffy nose, body aches, headache, chills and fatigue. A significant number of people who have been infected with novel H1N1 flu virus also have reported diarrhea and vomiting. The high risk groups for novel H1N1 flu are not known at this time, but it’s possible that they may be the same as for seasonal influenza. People at higher risk of serious complications from seasonal flu include people age 65 years and older, children younger than 5 years old, pregnant women, people of any age with chronic medical conditions (such as asthma, diabetes, or heart disease), and people who are immunosuppressed (e.g., taking immunosuppressive medications, infected with HIV).
There are two influenza antiviral medications that are recommended for use against novel H1N1 flu. The drugs that are used for treating novel H1N1 flu are called oseltamivir (trade name Tamiflu ®) and zanamivir (Relenza ®). As the novel H1N1 flu spreads, these antiviral drugs may become in short supply. Therefore, the drugs may be given first to those people who have been hospitalized or are at high risk of severe illness from flu. The drugs work best if given within 2 days of becoming ill, but may be given later if illness is severe or for those at a high risk for complications.
Posted: 金 - 8 月 21, 2009 at 12:01 午後 |
Quick Links
Comments
Categories
Archives
nakanohito
ClusterMap
GeoVisit
Counter
Shinobi
Swine Flu Info
Statistics
Total entries in this blog:
Total entries in this category:
Published On: 8 月 21, 2009 05:51 午後
Total entries in this category:
Published On: 8 月 21, 2009 05:51 午後